Several studies have demonstrated that the average life of organisms, including that of mammals, can be lengthened by acting on different genes. Until now this has included permanent modifications in animal genes starting in the embryonic phase, something which is not intended to be carried out with humans. Researchers at CNIO and CBATEG now have proved it possible to prolong the life of mice using a treatment which acts directly on the genes, but is used in adult animals and is applied only once. This is achieved through gene therapy, a strategy never before used to fight the aging process.
The therapy demonstrated to be safe and effective in mice. Researchers worked with adult mice aged one year and older mice aged two. In both cases the gene therapy had a "rejuvenating" effect. The mice which were treated at one year of age on average lived 24% longer.
This research is led at the Spanish National Cancer Research Centre (CNIO) by director Maria A. Blasco, in collaboration with Eduard Ayuso and Fátima Bosch, of the Centre for Animal Biotechnology and Gene Therapy (CBATEG) at the Universitat Autonoma de Barcelona UAB, Spain.